Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML)
Kenealy, Melita, Patton, Nigel, Filshie, Robin, Nicol, Andrew, Ho, Shir-Jing, Hertzberg, Mark, Mills, Tony, Prosser, Ian, Link, Emma, Cowan, Linda, Zannino, Diana, Seymour, John F.Langue:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2016.1190971
Date:
June, 2016
Fichier:
PDF, 1.27 MB
english, 2016